Menu
Currency
GWAS Study

Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.

Yu H, Wang L, Lv L et al.

26656879 PubMed ID
GWAS Study Type
1081 Participants
57 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

YH
Yu H
WL
Wang L
LL
Lv L
MC
Ma C
DB
Du B
LT
Lu T
JC
Jin C
YH
Yan H
YY
Yang Y
LW
Li W
RY
Ruan Y
ZH
Zhang H
ZH
Zhang H
MW
Mi W
MB
Mowry B
MW
Ma W
LK
Li K
ZD
Zhang D
YW
Yue W
Chapter II

Abstract

Summary of the research findings

Antipsychotic-induced weight gain (AIWG) is a serious concern in therapy with antipsychotic medications. To identify single nucleotide polymorphisms (SNPs) associated with AIWG, we conducted a genome-wide association study (GWAS) for antipsychotic treatment.

534 Han Chinese ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1081
Total Participants
GWAS
Study Type
Yes
Replicated
547 East Asian ancestry individuals
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.